흡입 일산화질소 전달 시스템 시장 규모, 점유율, 성장 분석 : 시스템 유형별, 용도별, 최종사용자별, 유통 경로별, 지역별 - 업계 예측(2026-2033년)

Global Inhaled Nitric Oxide Delivery Systems Market size was valued at USD 0.882 Billion in 2024 and is poised to grow from USD 0.96 Billion in 2025 to USD 1.852 Billion by 2033, growing at a CAGR of 8.62% during the forecast period (2026-2033).

The global inhaled nitric oxide delivery systems market is predominantly driven by the clinical need for effective pulmonary vasodilation therapies, which enhance oxygenation and address ventilation-perfusion mismatches, especially in neonatal intensive care. This sector, which includes gas delivery systems, monitoring devices, and disposable accessories, plays a crucial role in reducing morbidity and mortality rates associated with conditions like persistent pulmonary hypertension and acute respiratory distress syndrome. Technological advancements have transitioned the market from traditional bulk gas systems to innovative, portable delivery platforms. Notably, the surge in clinical applications during the COVID-19 pandemic underscored the need for efficient nitric oxide delivery, prompting manufacturers to develop compact systems with automated controls. Additionally, favorable reimbursement pathways and strategic partnerships have catalyzed wider adoption across various medical settings.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhaled Nitric Oxide Delivery Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhaled Nitric Oxide Delivery Systems Market Segments Analysis

Global inhaled nitric oxide delivery systems market is segmented by system type, application, end-user, distribution and region. Based on system type, the market is segmented into Cylinder-Based Delivery Systems and Generator-Based Systems. Based on application, the market is segmented into Persistent Pulmonary Hypertension of the Newborn (PPHN), Acute Respiratory Distress Syndrome (ARDS) and Cardiac Surgery. Based on end-user, the market is segmented into NICUs, ICUs and Cardiac Surgical Centers. Based on distribution, the market is segmented into Direct Sales and Distributors. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Inhaled Nitric Oxide Delivery Systems Market

A key market driver for the Global Inhaled Nitric Oxide Delivery Systems market is the increasing prevalence of respiratory conditions, such as acute respiratory distress syndrome (ARDS) and pulmonary hypertension, which necessitate advanced therapeutic interventions. The growing recognition of inhaled nitric oxide's efficacy in improving oxygenation and reducing pulmonary vascular resistance has spurred demand in both hospital and clinical settings. Additionally, ongoing innovations in delivery systems, coupled with the rising focus on patient-centered care and personalized medicine, are further propelling the adoption of these systems. This trend is expected to enhance patient outcomes and drive market growth significantly.

Restraints in the Global Inhaled Nitric Oxide Delivery Systems Market

One key market restraint for the global inhaled nitric oxide delivery systems market is the strict regulatory landscape governing the approval and use of medical devices. The lengthy and complex regulatory approval processes can significantly delay the introduction of innovative products into the market. Additionally, the high costs associated with compliance and the need for extensive clinical trials can deter smaller companies from entering the market. This regulatory burden, coupled with the limited range of indications for inhaled nitric oxide therapy, restricts market growth and the ability to capitalize on emerging opportunities in various therapeutic areas.

Market Trends of the Global Inhaled Nitric Oxide Delivery Systems Market

The Global Inhaled Nitric Oxide Delivery Systems market is witnessing a significant trend towards the expansion of clinical indications beyond its established role in neonatal care. The technology is increasingly being recognized in adult critical care and a variety of pulmonary disorders, as clinicians explore innovative therapeutic applications such as perioperative uses and targeted pulmonary vasodilation for patients with complex comorbidities. This shift is indicative of greater interdisciplinary collaboration and evolving clinical guidelines focused on personalized medicine. Manufacturers are responding by enhancing their offerings to accommodate diverse clinical workflows and supporting evidence generation to demonstrate the real-world efficacy of these systems, thereby optimizing treatment pathways for varied patient populations.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Inhaled Nitric Oxide Delivery Systems Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Cylinder-Based Delivery Systems
• Generator-Based Systems

Global Inhaled Nitric Oxide Delivery Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• Persistent Pulmonary Hypertension of the Newborn (PPHN)
• Acute Respiratory Distress Syndrome (ARDS)
• Cardiac Surgery

Global Inhaled Nitric Oxide Delivery Systems Market Size by End-User & CAGR (2026-2033)

• Market Overview
• NICUs
• ICUs
• Cardiac Surgical Centers

Global Inhaled Nitric Oxide Delivery Systems Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Distributors

Global Inhaled Nitric Oxide Delivery Systems Market Size & CAGR (2026-2033)

• North America (System Type, Application, End-User, Distribution)
  • US
  • Canada
• Europe (System Type, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (System Type, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (System Type, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (System Type, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Mallinckrodt Pharmaceuticals (INOmax)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bellerophon Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeNO LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vero Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SensorMedics (CareFusion/BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Air Liquide Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Praxair (Linde)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Air Products Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BOC Healthcare (Linde)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Messer Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOxBOX (Advanced Inhalation Therapies)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Inhalation Therapies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxygen Biotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CIRCOR International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neodiagnostix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vapotherm Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fisher & Paykel Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations